# Selonsertib in Adults With Pulmonary Arterial Hypertension

Study · id `cardio:ct-nct02234141` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02234141](<https://clinicaltrials.gov/study/NCT02234141>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02234141

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT02234141. Randomized; double masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2019-04-10.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Start date: 2014-11 (registry gives no type) (ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Primary completion: 2016-04 (actual) (ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Results first posted: 2019-04-10 (ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Countries: United States; Canada; France; Germany; Italy; Netherlands; Spain; United Kingdom (ClinicalTrials.gov record NCT02234141, source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02234141-2019-04-10`, retrieved 2026-10-31)

## The registry's words

- Brief title: Selonsertib in Adults With Pulmonary Arterial Hypertension
- Acronym: ARROW
- Condition: Pulmonary Arterial Hypertension
- Intervention (Drug): Placebo
- Intervention (Drug): Selonsertib
- Lead sponsor: Gilead Sciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary arterial hypertension (`cardio:pulmonary-arterial-hypertension`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: Gilead Sciences (`cardio:org-gilead-sciences`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial (`cardio:pubmed-34425071`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b018ed40e66612b22484d99c98480121859d1b51122e5c425a1d604827d01185
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
